Are Generics still the Underdogs? Insights into Indian Consumers’ views on Medicine Quality and Savings
Indian consumers doubt generic drug quality despite their cost benefits. Most are open to switching with doctor's OK, but better.
Indian Pharmaceutical Market
Monthly Sales November 2025
INR
20000
Cr.
YOY Growth November 2025
5
%
Key Performance Drivers
The growth was not uniform across all factors, but rather driven by specific levers:
- Price Increases: Contributed approximately 5.5% to the growth.
- New Product Introductions (NPIs): Added 2.9%, showing a shift toward innovation-led revenue.
- Volume Growth: Remained modest at 0.6%, indicating that while people are paying more for newer or adjusted medicines, the actual quantity of units sold is growing slowly.
Therapy & Segment Highlights
- Chronic vs. Acute: The Chronic segment (medicines for long-term conditions like heart disease and diabetes) continues to be the powerhouse, growing at 13.3% YoY. The Acute segment (for short-term illnesses like infections) saw more muted growth.
- Top Therapies: * Cardiac and Anti-Diabetic therapies were major contributors.
- GLP-1 agonists (like Semaglutide/Wegovy and Tirzepatide/Mounjaro) have emerged as significant “growth anchors,” reflecting a massive shift in how metabolic health and obesity are being treated in India.
- Regional Performance: The South Zone led the country in growth, largely due to a higher uptake of chronic therapies.
10Feb
Are Generics still the Underdogs? Insights into Indian Consumers’ views on Medicine Quality and Savings
Indian consumers doubt generic drug quality despite their cost benefits. Most are open to switching with doctor's OK, but better.
07Jan
Digital Marketing in Indian Pharma: MNC vs Domestic Adoption Trends (2025 Study)
New 2025 study of 199 pharma pros reveals MNCs lead in AI, SEO & omnichannel HCP engagement. Domestic firms lag.
26Dec
The Unstoppable Force: Maximizing Pharma Field Force Effectiveness Through Strategic Refresher Training
In the pharma world, doctors switch prescribing habits fast. Specifically, A 2023 study from IQVIA showed that new guidelines can.
What We DO
Effective pharma marketing requires understanding markets and audiences. We provide research and analysis to identify opportunities, threats, and buyer personas.
View More
Marketing strategy aligns business goals with pharma challenges through research, targeting, and brand positioning. We help companies create effective, aligned strategies.
View More
Creative development crafts engaging marketing campaigns that resonate and differentiate brands. We also develop materials like ads, brochures, and website content.
View More
Pharma companies need digital marketing to reach audiences. We offer SEO, PPC, and social media campaigns.
View More
Pharma uses events and webinars to educate HCPs on products, services, and research via conferences, workshops, etc.
View More
We create content strategies and engaging content (blogs, websites, social media & more) to meet your business goals.
View More
